(ATDN) 3TC Expanded Access Update

(ATDN) 3TC Expanded Access Update

Treatment Review #18; April 1995

The 3TC Expanded Access program has slowed down. Some members report a four to six week wait before they receive approval to get onto this program sponsored by the manufacturer of the drug, Glaxo Inc. Glaxo provides this drug free of charge to physicians who request it for their patients who have failed other antiretroviral drugs. People must have less than 100 T-cells to get into the program.

The 3TC Expanded Access program is included in the latest version of The Experimental Treatment Guide, The Network's directory of clinical trials and treatment programs. For a free copy of the new Spring edition of this directory call our national toll-free treatment information number: (800) 734-7104.

950401
ATR01810

Always watch for outdated information. This article first appeard in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

Copyright © 1995 - AIDS Treatment Data Network. If you want to copy, reproduce or excerpt this information, please give us a call at (800) 734-7104. This helps up to keep track of where and how this information is being used. You can also Email us at network@atdn.org http://206.179.124.69/network/index.html

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1995. AEGIS.